|
N-[3-(2-amino-1H-imidazol-5-yl)phenyl]adamantane-1-carboxamide;hydrochloride |
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
1-[3-(2-amino-1H-imidazol-5-yl)phenyl]-3-(3,4-dichlorophenyl)urea |
Depiction based on curated SMILES
H
2
N
HN
N
Cl
Cl
NH
O
N
H
|
Francisella |
Regulation |
Preclinical (in vitro) |
Milton ME, et al. 2017. Mol Microbiol |
|
(4Z)-4-benzylidene-2-phenyl-5-(trifluoromethyl)pyrazol-3-one |
Depiction based on curated SMILES
F
F
F
O
N
N
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
(4-bromo-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-3-yl)methyl imidothiocarbamate |
Depiction based on curated SMILES
H
2
N
NH
S
Br
H
3
C
N
O
N
|
Helicobacter |
Flagella |
Preclinical (in vitro) |
Suerbaum S, et al. 2022. mBio |
|
3-[5-chloro-2-(3-sulfopropylsulfanyl)-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid |
Depiction based on curated SMILES
HO
O
O
S
OH
O
O
S
S
S
+
N
Cl
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Mori M, et al. 2014. Bioorg Med Chem Lett |
|
S-(2,4-difluorophenyl) 2-[5-[4-(trifluoromethyl)phenyl]tetrazol-2-yl]ethanethioate |
Depiction based on curated SMILES
O
F
F
F
F
F
S
N
N
N
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
(2Z)-2-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-7,8-dimethyl[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one |
Depiction based on curated SMILES
H
3
C
OH
Cl
O
N
H
3
C
CH
3
N
S
O
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother
|
|
5beta,6alpha-Bis(4-cyclopropyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
2
N
N
H
N
N
N
N
H
H
N
N
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
(E)-3-(4-Acetyl-phenyl)-N-[4-(1-hydroxy-6-nitro-1H-benzoimidazol-2-yl)-phenyl]-acrylamide |
Depiction based on curated SMILES
N
+
N
O
_
O
N
HO
H
3
C
N
H
O
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
(E)-3-(4-acetylphenyl)-N-(4-(6-cyano-1-hydroxy-1H-benzo[d]imidazol-2-yl)phenyl)acrylamide |
Depiction based on curated SMILES
HO
N
N
N
H
3
C
N
H
O
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
| | |